• Email Preferences
    • Logout
    loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
    • Email Preferences
    • Logout
    loading
    Member
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 93
  3. 94
  4. 95
  5. 96
  6. 97
  7. …
  • Sinopharm COVID-19 vaccine trial temporarily suspended

    Peru // 12 December, 2020

    A "serious adverse event" has been reported in a trial participant....

    COVID-19

  • Encouraging Phase 1 trial results of Novavax vaccine

    12 December, 2020

    Novovax announces encouraging results of early NVX‑CoV2373 vaccine trials...

    COVID-19

  • SARS-CoV-2 found in Milan in December 2019

    Italy // 12 December, 2020

    Evidence of SARS-CoV-2 virus has been found in Milan three months before the first diagnosed case…

    COVID-19

  • COVID-19 risk calculator

    United States // 12 December, 2020

    A mortality risk calculator for COVID-19 has been developed by Johns Hopkins University....

    COVID-19

  • Five genes linked to increased risk of severe disease identified

    12 December, 2020

    Genetic differences may explain why some people have mild disease while for others COVID-19 is fatal...

    COVID-19

  • Pfizer-BioNTech vaccine approved in Mexico

    Mexico // 12 December, 2020

    Mexico became the first Latin-American country to grant emergency use authorisation of a COVID-19 vaccine...

    COVID-19

  • FDA issues EUA for Baricitinib treatment of hospitalised patients

    United States // 12 December, 2020

    The rheumatoid arthritis treatment has been granted an EUA in the US and study results have been published...

    COVID-19

  • Quarantine period shortened to 10 days

    United Kingdom // 11 December, 2020

    The period for quarantine after exposure or travel is now 10 days...

    COVID-19

  • Assessing the efficiencies of cloth masks and improvised face coverings during COVID-19 pandemic, study

    11 December, 2020

    The study analyses effectiveness of cloth masks and modified medical procedure masks...

    COVID-19

  • AstraZeneca begins clinical trials in combination with Sputnik V

    11 December, 2020

    For better immune response and better protection...

    COVID-19

  • Sanofi and GSK announce a delay in COVID-19 vaccine program

    11 December, 2020

    Delay in vaccine programme...

    COVID-19

  • Study: Airborne transmission inside a South Korean restaurant

    South Korea // 11 December, 2020

    A study has found airborne transmission of COVID-19 occurred at longer distances and shorter times than previously identified…

    COVID-19

  • Australian COVID-19 vaccine terminated due to HIV false positives

    Australia // 11 December, 2020

    While the vaccine showed good efficacy with minimal safety concerns, an unexpected interruption with HIV tests was found…

    COVID-19

  • US faces “dark time” with holiday COVID-19 surges, Fauci says

    United States // 10 December, 2020

    Dr Fauci warns that the holiday season will bring an overwhelming surge in cases...

    COVID-19

  • No alcohol for 2 months, Russia tells coronavirus vaccine recipients

    Russia // 10 December, 2020

    Russia warns coronavirus vaccine recipients to abstain from alcohol, as vaccine supplies are distributed nationwide...

    COVID-19

  • Mexico to launch COVID-19 vaccinations this month

    Mexico // 10 December, 2020

    The Pfizer-BioNTech vaccine to be rolled out to priority groups…

    COVID-19

  • Air freight prices 'outrageous' as COVID-19 shots rolled out, says WHO expert

    10 December, 2020

    The WHO finds that distribution of COVID-19 vaccines will be tricky in some places…

    COVID-19

  • Severe Cases More Likely in Men

    10 December, 2020

    Study finds men are three times more likely to require intensive care than women…

    COVID-19, General Articles

  • Mortality among adults ages 25-44 in the US during the COVID-19 pandemic

    United States // 10 December, 2020

    A new analysis shows that COVID-19 is now the leading cause of...

    COVID-19

  • Attack rate of 75 percent in the Brazilian Amazon

    Brazil // 10 December, 2020

    An article reports that SARS-CoV-2 spread rapidly in the Brazilian Amazon...

    COVID-19

  1. …
  2. 93
  3. 94
  4. 95
  5. 96
  6. 97
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS